Expression of the retroviral vector Neor myeloproliferative sarcoma virus (MPSV), which contains the v-mos oncogene and the neomycin resistance gene, leads to neoplastic transformation of mouse fibroblasts. Murine recombinant gamma interferon (IFN--y) could revert the neoplastic properties of established Neor MPSVtransformed cell lines to an apparently untransformed phenotype. In the presence of IFN-y, the Neor MPSV transformants showed a greater than 97% reduction of cloning efficiency in soft agar, strongly reduced proliferative capacity, and morphological changes. The IFN-y-induced phenotypic reversion was preceded by a rapid and selective reduction of all retroviral RNA species, apparently due to IFN--y action on the long terminal repeat of Neor MPSV. The mRNA levels of cellular genes either remained unaffected (,I-actin) or were even enhanced (H-2) in IFN-y-treated Neor MPSV-transformed cells. Upon removal of IFN-y, retroviral gene expression was fully recovered and a gradual reappearance of the transformed phenotype of these cells within 3 weeks was noted. These data show that IFN-'y can cause a virtually complete, but reversible, inhibition of v-mos-induced neoplastic properties in transformed fibroblasts by selective down regulation of retroviral RNA levels.
Type I and type II interferons (IFNs) exhibit multip. biological activities, including antiviral, antitumor, and immunodulatory action (5, 10, 12, 18) . In sensitive cells, IFN treatment causes marked changes in the expression of genes involved in the regulation of cell proliferation, differentiation, and cell surface antigen expression (4) . In several tumor cells, alpha/beta interferon (IFN-a/p) treatment leads to a reversal of the transformed and tumorigenic phenotype (1, 2, 14, 32, 33, 35, 36) . So far, the respective molecular mechanisms are not fully understood. However, in some experimental models, IFN-a or IFN-, treatment has been shown to modulate the expression of cellular and viral oncogenes (4) . The level at which oncogene expression is affected by type I IFNs is still controversial (8, 20, 31) . Nevertheless, in some human and murine cell lines, IFNmediated reduction of c-onc expression appeared to correlate with reduction of in vitro proliferation and tumorigenicity (20, 30) . To date, little information is available on whether gamma interferon (IFN--y), which exerts strong cytostatic activity on various tumor cells (5, 19) , has a direct effect on oncogene-mediated transformation of cells. We have addressed this question by studying the effects of murine recombinant IFN-y on v-mos-induced transformation of mouse fibroblasts with the retroviral vector Neor myeloproliferative sarcoma virus (MPSV). Neor MPSV is a derivative of MPSV (21, 28) carrying the v-mos oncogene and the dominant selection marker for neomycin resistance (Neor) (27) . It has recently been shown that continuous expression of the v-mos gene (26) but only low levels of mos gene product (29) are required to maintain the transformed phenotype of fibroblasts. We report here that IFN-y reversibly inhibits v-mos-induced transformed properties of established neoplastic cells because of selective down regulation of retroviral RNA levels. * Corresponding author.
MATERIALS AND METHODS
Plasmids and probes. The retroviral vectors Neor MPSV and Neor mos-, derivatives of MPSV (21, 28) , were previously described in detail (27) and are represented schematically in Fig. 1 .
Plasmid pMS1 (25) , containing the c-mos gene, was used to detect mos-specific sequences. pAG60 (7), containing the Neor coding region, was used for detection of neo-specific sequences. Plasmid pB2M13, containing the 5' long terminal repeat (LTR) of Mov-13 murine leukemia virus (15) , was used for the LTR-specific probe. Plasmid pH-2d-4 was used to detect H-2-specific sequences (23) . The plasmid pAl was used to detect P-actin-specific sequences (6) .
Cell lines and cell culture. 3T3mosl, -2, -3, and -4 are neomycin-resistant, transformed clones of NIH 3T3, which contain one full-length copy of Neor MPSV. Northern blot (RNA blot) analysis. Total cellular RNA was extracted with guanidine isothiocyanate by the methods described by Chirgwin et al. (3) . RNA (20 ,ug per lane) was electrophoresed in 1% agarose gels containing 0.2 M MOPS (3-N-morpholinepropanesulfonic acid) buffer, 50 mM sodium acetate, 5 mM EDTA, pH 8.0, and 6% formaldehyde, and gels were blotted onto nitrocellulose filters with 3 M NaCI-0.3 M sodium citrate (pH 7.0) as previously described (15) . Filters were hybridized to specific probes labeled with 32p by random priming as described by Feinberg and Vogelstein (11) . The filters were then washed and exposed to X-ray film at -70°C in the presence of Cronex LightningPlus intensifying screens. 
RESULTS
To determine whether murine recombinant IFN-y inhibits v-mos-induced transformation of fibroblasts, studies were performed with established, cloned Neor MPSV-transformed NIH 3T3 cell lines, designated 3T3mosl, -2, -3, and -4. The effect of IFN-y on colony formation of these cell lines was determined by comparing the plating efficiencies of 3T3mosl, -2, -3, and -4 in soft agar in the presence or absence of IFN-'y. Parental NIH 3T3 cells and 3T3mos-1 cells served as a control. The data obtained (Table 1) demonstrate that in contrast to untransformed NIH 3T3 and 3T3mos-1 cells, the Neor MPSV-transformed clones 3T3mosl, -2, -3, and -4 displayed a high colony-forming efficiency in soft agar, ranging from 76 to 92%. In the presence of 400 IU of IFN--y per ml, only very few colonies (4 to 8 per 500 cells plated) developed. Thus, colony formation of Neor MPSV transformants in soft agar was reduced to about 1 to 2% of that of untreated control cultures. Similarly, in liquid culture, IFN--y largely inhibits focus formation of Neor MPSV-transformed cells. For example, upon 48 h of culture in the presence of IFN--y, 3T3mos4 cells remained spread out and tightly attached to the surface with little evidence of focus formation, which is detectable in untreated 3T3mos4 cells after 2 days of culture (Fig. 2) . Together, these data show that IFN--y treatment of Neor MPSVtransformed cells inhibited their capacity for anchorageindependent growth. During the entire culture period, no cytotoxic effect of IFN--y on either retrovirus-transformed or parental NIH 3T3 cells was noted. However, IFN--y differentially affected the growth of parental and retrovirustransformed fibroblasts. To assess the IFN--y effect on cell growth, the various cell lines were seeded at low density and were either left untreated or exposed to 400 IU of IFN--y per ml. The total number of cells and viability was determined at 2-day intervals. Typical growth curves for two v-mos transformants, 3T3mos2 and 3T3mos4, as well as for the control cell lines, are shown in To investigate whether IFN-y affects overall cellular mRNA expression in these cells, we also examined the constitutively expressed genes 1-actin and H-2. Representative results from one v-mos-transformed clone (3T3mos4) and the respective control cell line (3T3mos-l) are shown in Fig.  4 . In untreated 3T3mos4 cells, Neor MPSV-specific sequences of 8.1 kb can be detected with either a neo-or a mos-specific probe. Treatment of these cells for 24 h with 400 IU of IFN--y per ml strongly reduced both the Neor and v-mos RNA levels (Fig. 4, lane 4 versus lane 3) . As the expression of Neor and v-mos is under the control of the MPSV-derived LTR, the concomitant down regulation of RNA levels of both genes suggested the influence of IFN-y on these regulatory sequences. Hybridization of the same blot with an LTR-specific probe further supported this prediction. Similar results were obtained with 3T3mos-1 cells (Fig. 4, lane 2 versus lane 1) . The IFN--y-mediated down regulation of retrovirus-specific RNA levels was selective in that constitutively expressed celllular genes either remained unaffected (,-actin) or were even enhanced (H-2) in both 3T3mos-1 cells (Fig. 4 , lane 1 versus lane 2) and 3T3mos4 cells (Fig. 4, lane 3 (Fig. 7, lane 1) , 48 h after IFN--y treatment (Fig. 7, lane 2) , and 3 weeks after the removal of IFN--y (Fig. 7, lane 3) . The data show that 3 weeks after ending IFN--y treatment, high levels of retroviral RNA were again present in these 3T3mos4 cells.
In subsequent experiments, we confirmed that retransformation of 3T3mos4 upon ending IFN-y treatment indeed occurs at a high frequency. Thus, to rule out that a few retransformants, because of their growth advantage, overgrow a majority of stable, nontransformed revertants, cloning in liquid culture was performed with 3T3mos4 cells directly after a phenotypical reversion induced by 48 h of IFN--y treatment. The overall cloning efficiency, as well as the number of morphologically transformed colonies, was determined in comparison to untreated 3T3mos4 cells, as well as to untransformed 3T3mos-l and parental NIH 3T3 cells. The various cell lines show a similar cloning efficiency of approximately 70%, independent of pretreatment with IFN-y ( Table 2) . As expected, all the colonies of untreated 3T3mos4 cells, but none of the 3T3mos-l and NIH 3T3 colonies, exerted the typical transformed morphology shown in Fig. 2 . Interestingly, 65 out of 70 colonies obtained from the IFN--y-pretreated, i.e., reverted, 3T3mos4 cells again show a transformed morphology 21 days after plating (Table  2 ). These data indicate that the development of retransformants from reverted 3T3mos4 cells is a frequent occurrence, which affects the vast majority of the reverted population and is linked to ending IFN--y treatment.
DISCUSSION
We show here that murine recombinant IFN-y exerts a strong, but reversible, inhibition of retroviral gene expression in established Neor MPSV-transformed cell lines, thereby inducing phenotypical and morphological reversion of v-mos-transformed cells. These data indicate that IFN--y may exert antitumor activity by down regulation of oncogene expression which is under control of retroviral promoters.
The retroviral vector Neor MPSV is able to transmit and coexpress both the Neor gene and the mos oncogene in fibroblasts, the latter of which causes neoplastic transformation (27) . Although it has been reported that IFN treatment may result in the loss of integrated proviral DNA (36) , with the retroviral vector studied here, integration was not affected by IFN--y treatment. Therefore, established Neor MPSV-transformed cell lines could be used as a model to study the influence of IFN--y on the expression of the v-mos oncogene and its correlation with the transformed properties of fibroblasts.
In Neor MPSV transformants, a full-length Neor MPSVspecific primary transcript of 8.1 kb was detectable with both Neor-and mos-specific probes. In addition, a specific 2.6-kb transcript was found, representing mature v-mos mRNA. Both the full-length transcript and the mature v-mos-specific transcript were down regulated by IFN-y treatment (Fig. 4 and 5 However, IFN--y is effective on parental 3T3 cells with respect to enhancement of H-2 gene expression, similar to the response seen in v-mos-transformed 3T3 cells (Fig. 4) . It is worth mentioning here that, in general, mean H-2 expression in v-mos-transformed 3T3 clones was found to be significantly lower compared with nontransformed parental 3T3 clones. The lower levels of H-2-specific mRNA in transformed cells were paralleled by a reduced level of membrane antigen expression (data not shown). This finding appears important in the light of recent data suggesting that an inverse relationship between major histocompatibility complex antigen expression and tumorigenicity of some tumors exists (13) . Thus, IFN--y-mediated enhancement of H-2 expression in Neor MPSV-transformed 3T3 cells can be taken as an additional indicator of reversion of these cells to a nontumorigenic, normal phenotype. These data further illustrate the multifunctional nature of IFN--y and the contribution of distinct IFN-y actions to the inhibition of neoplastic properties of transformed cells.
In regard to the mechanisms of IFN-y action on v-mos oncogene expression, it is conceivable that IFN--y regulates expression of the mos gene by affecting the transcriptional activity of the retroviral promoters (LTR). Our data obtained with 3T3mos4 and 3T3mos-1 cells show comparable reduction of RNA levels of all retroviral genes, independent of the presence of the v-mos oncogene. Thus, for the model described here, down regulation of oncogene expression could be explained, on one hand, by the effects of IFN-y on LTR activity. On the other hand, IFN-y could induce additional mechanisms in Neor MPSV cells, which contribute to the down regulation of retroviral gene expression, e.g., via enhancement of RNA degradation, as described in other experimental systems (17) . However, very recent data from our own laboratory indicate that IFN-y has no profound effect on retroviral RNA half-life but instead inhibits transcriptional activity of retroviral genes (B. Seliger, G. Kruppa, R. Schifer, and K. Pfizenmaier, submitted for publication).
The data presented here extend previous findings on the action of IFN-a/p on viral and cellular oncogenes (8, 9, 16, 17, 20, 30, 32, 33) (35) . In the latter model, stable phenotypical reversion was achieved despite expression of the v-mos oncogene, pointing out that distinct cellular pathways are activated by IFN-a/,B and IFN--y, both of which can eventually lead to the inhibition of a tumorigenic phenotype.
